marketcaparena
Search

    VSTM

    Verastem, Inc.

    Company overview

    Market capitalization
    $703.68M
    Employees
    102
    Latest publication
    2026-09-29
    About Verastem, Inc.

    Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors. The company is involved in clinical studies, including RAMP 301, a randomized global confirmatory trial to evaluate the combination of Avutometinib and Defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer; RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of Avutometinib and in combination with Defactinib; and FRAME, an investigation of Avutometinib and Defactinib in patients with KRAS mutant cancers and subsequent analyses; and RAMP 205. It has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing Avutometinib; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic, and prophylactic uses in humans. In addition, it has a clinical collaboration agreement with Amgen, Inc. to evaluate the combination of Avutometinib with Amgen's KRAS-G12C inhibitor LUMAKRAS, which in Phase 1/2 trial entitled RAMP 203; VS-7375, and VS-7375-101 is a discovery and development collaboration with GenFleet Therapeutics to advance new programs targeting RAS pathway-driven cancers; and AVMAPKI, FAKZYNJA, CO-PACK, is an avutometinib capsules, and defactinib tablets. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
    Total Revenue2,137,000USD0USD-9,976,000USD10,000,000USD0USD2,596,000USD0USD0USD
    Cost Of Revenue446,000USD10,000USD12,000USD6,000USD6,000USD29,000USD30,000USD29,000USD
    Gross Profit1,691,000USD-10,000USD-9,988,000USD10,000,000USD-6,000USD2,567,000USD-30,000USD-29,000USD
    Research Development24,786,000USD29,152,000USD20,811,000USD18,062,000USD17,707,000USD10,740,000USD11,288,000USD14,888,000USD
    Selling General Administrative20,669,000USD15,022,000USD10,779,000USD10,215,000USD10,352,000USD6,106,000USD6,421,000USD6,514,000USD
    Total Operating Expenses45,455,000USD44,174,000USD31,590,000USD28,277,000USD28,059,000USD16,846,000USD17,709,000USD21,402,000USD
    Operating Income-43,764,000USD-44,174,000USD-31,590,000USD-18,277,000USD-28,059,000USD-16,846,000USD-17,709,000USD-21,402,000USD
    Interest Income822,000USD960,000USD968,000USD983,000USD1,367,000USD769,000USD316,000USD84,000USD
    Interest Expense212,000USD192,000USD1,146,000USD1,138,000USD1,130,000USD724,000USD717,000USD640,000USD
    Net Interest Income610,000USD768,000USD-178,000USD-155,000USD237,000USD45,000USD-401,000USD-556,000USD
    Income Before Tax-25,934,000USD-52,103,000USD-64,366,000USD-8,256,000USD-33,863,000USD-16,808,000USD-18,090,000USD-21,952,000USD
    Net Income-25,934,000USD-52,103,000USD-64,551,000USD-8,256,000USD-33,863,000USD-16,808,000USD-18,090,000USD-21,952,000USD
    Net Income From Continuing Ops-25,934,000USD-52,103,000USD-64,551,000USD-8,256,000USD-33,863,000USD-16,808,000USD-18,090,000USD-21,952,000USD
    Ebit-25,722,000USD-51,911,000USD-63,220,000USD-7,118,000USD-32,733,000USD-16,072,000USD-17,362,000USD-21,306,000USD
    Ebitda-25,594,000USD-51,901,000USD-63,213,000USD-7,112,000USD-32,727,000USD-16,084,000USD-17,373,000USD-21,312,000USD
    Depreciation And Amortization128,000USD10,000USD7,000USD6,000USD6,000USD-12,000USD-11,000USD-6,000USD
    Reconciled Depreciation128,000USD10,000USD7,000USD52,000USD-40,000USD-12,000USD-11,000USD-6,000USD
    Total Other Income Expense Net17,830,000USD-7,929,000USD-32,776,000USD10,021,000USD-5,804,000USD38,000USD-381,000USD-550,000USD
    Income Tax Expense——185,000USD—-37,276USD12,000USD11,000USD652,000USD
    Non Operating Income Net Other—————762,000USD336,000USD90,000USD
    Net Income Applicable To Common Shares—————-16,808,000USD-18,090,000USD-21,952,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20222022-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USD
    Total Revenue10,000,000USD2,596,000USD0USD0USD0USD0USD0USD0USD
    Cost Of Revenue26,000USD118,000USD556,000USD670,000USD754,000USD0USD0USD0USD
    Gross Profit10,000,000USD2,596,000USD-556,000USD-670,000USD-754,000USD0USD0USD0USD
    Research Development81,334,000USD50,558,000USD46,423,000USD19,779,000USD40,565,000USD35,448,000USD25,930,000USD21,712,000USD
    Selling General Administrative43,622,000USD24,975,000USD21,381,000USD17,223,000USD17,634,000USD18,159,000USD15,472,000USD10,518,000USD
    Total Operating Expenses124,956,000USD75,533,000USD67,804,000USD37,002,000USD58,199,000USD53,607,000USD41,402,000USD32,230,000USD
    Operating Income-114,956,000USD-72,937,000USD-67,804,000USD-37,002,000USD-58,199,000USD-53,607,000USD-41,402,000USD-32,230,000USD
    Interest Income4,149,000USD1,215,000USD561,000USD562,000USD————
    Interest Expense4,562,000USD2,137,000USD559,000USD0USD0USD0USD0USD0USD
    Net Interest Income-413,000USD-922,000USD2,000USD562,000USD————
    Income Before Tax-130,452,000USD-73,812,000USD-67,802,000USD-36,440,000USD-57,865,000USD-53,365,000USD-41,202,000USD-31,984,000USD
    Income Tax Expense185,000USD36,000USD561,000USD0USD-754,000USD0USD0USD0USD
    Tax Provision185,000USD0USD——————
    Net Income-130,637,000USD-73,812,000USD-67,802,000USD-36,440,000USD-57,865,000USD-53,365,000USD-41,202,000USD-31,984,000USD
    Net Income From Continuing Ops-130,637,000USD-73,812,000USD-67,802,000USD-36,440,000USD-57,865,000USD-53,365,000USD-41,202,000USD-31,984,000USD
    Ebit-125,890,000USD-71,675,000USD-67,243,000USD-36,440,000USD-58,199,000USD-53,365,000USD-41,202,000USD-31,984,000USD
    Ebitda-125,864,000USD-71,557,000USD-66,687,000USD-35,770,000USD-57,445,000USD-52,938,000USD-40,966,000USD-31,777,000USD
    Depreciation And Amortization26,000USD118,000USD556,000USD670,000USD754,000USD427,000USD236,000USD207,000USD
    Reconciled Depreciation26,000USD-36,000USD556,000USD—————
    Total Other Income Expense Net-15,496,000USD-875,000USD2,000USD562,000USD334,000USD242,000USD200,000USD15,000USD
    Non Operating Income Net Other—1,262,000USD561,000USD562,000USD334,000USD242,000USD200,000USD246,000USD
    Net Income Applicable To Common Shares—-73,812,000USD-67,802,000USD-36,440,000USD-57,865,000USD-53,365,000USD-41,202,000USD-31,990,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets227,808,000USD246,442,000USD176,852,000USD196,264,000USD131,698,000USD101,538,000USD126,378,000USD105,747,000USD
    Intangible Assets16,146,000USD16,426,000USD16,704,999USD15,636,000USD————
    Other Current Assets8,581,000USD7,577,000USD7,840,000USD6,507,000USD6,930,000USD5,943,000USD7,287,000USD5,450,000USD
    Total Liab146,031,000USD189,245,000USD192,378,000USD160,208,000USD164,131,000USD130,431,000USD94,159,000USD65,737,000USD
    Total Stockholder Equity81,777,000USD57,197,000USD-15,526,000USD36,056,000USD-32,433,000USD-28,893,000USD32,219,000USD40,010,000USD
    Other Current Liab50,954,000USD53,981,000USD44,721,000USD38,136,000USD25,391,000USD25,952,000USD22,153,000USD17,195,000USD
    Common Stock9,000USD8,000USD7,000USD6,000USD5,000USD4,000USD4,000USD3,000USD
    Capital Stock9,000USD8,000USD7,000USD6,000USD5,000USD4,000USD21,163,000USD21,162,000USD
    Retained Earnings-1,201,589,000USD-1,164,998,000USD-1,132,082,000USD-1,033,564,000USD-1,007,630,000USD-955,527,000USD-890,976,000USD-867,009,000USD
    Other Assets1USD——————1USD
    Cash165,551,000USD204,990,000USD137,706,000USD164,322,000USD117,569,000USD88,818,000USD113,175,000USD83,371,000USD
    Cash And Short Term Investments181,678,000USD213,803,000USD137,706,000USD164,322,000USD117,569,000USD88,818,000USD113,175,000USD83,371,000USD
    Total Current Assets202,904,000USD223,413,000USD154,056,000USD174,273,000USD124,699,000USD94,961,000USD120,662,000USD99,646,000USD
    Total Current Liabilities66,845,000USD72,268,000USD59,712,000USD50,361,000USD35,619,000USD30,973,000USD37,374,000USD30,347,000USD
    Net Debt-80,076,000USD-117,821,000USD-48,229,000USD-79,607,000USD-40,774,000USD-46,564,000USD-71,745,000USD-41,507,000USD
    Short Term Debt6,289,000USD5,839,000USD5,103,000USD4,178,000USD3,029,000USD995,000USD10,783,000USD6,474,000USD
    Short Long Term Debt5,795,000USD5,304,000USD4,310,000USD3,134,000USD2,010,000USD—10,003,000USD5,452,000USD
    Short Long Term Debt Total85,475,000USD87,169,000USD89,477,000USD84,715,000USD76,795,000USD42,254,000USD41,430,000USD41,864,000USD
    Long Term Debt76,870,000USD81,330,000USD84,374,000USD80,537,000USD73,495,000USD40,724,000USD30,647,000USD35,390,000USD
    Short Term Investments16,126,999USD8,813,000USD———0USD0USD0USD
    Net Receivables10,358,000USD200,000USD6,716,000USD2,276,000USD200,000USD200,000USD200,000USD10,825,000USD
    Inventory2,287,000USD1,833,000USD1,794,000USD1,168,000USD—0USD——
    Accounts Payable9,602,000USD12,448,000USD9,888,000USD8,047,000USD7,199,000USD4,026,000USD4,438,000USD6,678,000USD
    Property Plant Equipment Net2,793,000USD491,000USD750,000USD984,000USD1,210,000USD1,437,000USD664,000USD862,000USD
    Property Plant Equipment Gross2,793,000USD2,113,000USD750,000USD984,000USD1,210,000USD3,055,000USD664,000USD862,000USD
    Accumulated Other Comprehensive Income8,618,000USD5,229,000USD2,545,000USD5,290,000USD6,639,000USD—-21,159,000USD-21,159,000USD
    Common Stock Shares Outstanding99,148,000shares83,400,000shares73,157,000shares74,037,000shares54,173,000shares37,985,500shares40,258,000shares26,861,000shares
    Non Current Assets Total24,903,999USD23,029,000USD22,796,000USD21,991,000USD6,999,000USD6,577,000USD5,716,000USD6,101,000USD
    Non Current Liabilities Total79,186,000USD116,977,000USD132,666,000USD109,847,000USD128,512,000USD99,458,000USD56,785,000USD35,390,000USD
    Non Currrent Assets Other5,723,999USD6,112,000USD5,341,000USD5,371,000USD5,789,000USD5,140,000USD5,052,000USD5,239,000USD
    Net Working Capital136,059,000USD151,145,000USD94,344,000USD123,912,000USD89,080,000USD63,988,000USD83,288,000USD69,299,000USD
    Unclassified Current Liabilities-5,795,000USD-5,304,000USD-4,310,000USD-3,134,000USD-2,010,000USD—-10,003,000USD-5,452,000USD
    Unclassified Non Current Liabilities2,316,000USD35,647,000USD48,292,000USD29,310,000USD55,017,000USD58,734,000USD26,138,000USD—
    Unclassified Equity1,274,730,000USD1,216,950,000USD1,113,997,000USD1,064,318,000USD968,548,000USD926,626,000USD923,187,000USD907,013,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets246,442,000USD101,538,000USD149,718,000USD95,050,000USD108,662,000USD154,349,000USD145,046,000USD277,236,000USD
    Intangible Assets16,426,000USD—————20,008,000USD21,577,000USD
    Other Current Assets7,777,000USD5,943,000USD6,553,000USD4,945,000USD4,968,000USD3,473,000USD3,835,000USD2,973,000USD
    Total Liab189,245,000USD130,431,000USD92,344,000USD47,659,000USD21,103,000USD39,075,000USD137,872,000USD152,937,000USD
    Total Stockholder Equity57,197,000USD-28,893,000USD57,374,000USD47,391,000USD87,559,000USD115,274,000USD7,174,000USD124,299,000USD
    Other Current Liab59,285,000USD25,952,000USD18,255,000USD14,983,000USD15,621,000USD14,660,000USD19,815,000USD21,108,000USD
    Common Stock8,000USD4,000USD3,000USD20,000USD19,000USD17,000USD8,000USD7,000USD
    Capital Stock8,000USD4,000USD3,000USD20,000USD19,000USD17,000USD8,000USD7,000USD
    Retained Earnings-1,164,998,000USD-955,527,000USD-824,890,000USD-737,523,000USD-663,711,000USD-592,511,000USD-524,785,000USD-375,576,000USD
    Cash204,990,000USD88,818,000USD77,909,000USD74,933,000USD21,252,000USD67,782,000USD43,514,000USD129,867,000USD
    Cash And Short Term Investments204,990,000USD88,818,000USD137,129,000USD87,894,000USD100,256,000USD141,226,000USD75,506,000USD249,653,000USD
    Total Current Assets223,413,000USD94,961,000USD143,682,000USD92,870,000USD105,740,000USD144,938,000USD84,961,000USD253,259,000USD
    Total Current Liabilities72,268,000USD30,973,000USD26,380,000USD21,663,000USD18,590,000USD17,093,000USD29,890,000USD37,077,000USD
    Net Debt-128,125,000USD-46,564,000USD-36,352,000USD-47,868,000USD-18,072,000USD-45,242,000USD64,018,000USD-9,414,000USD
    Short Term Debt535,000USD995,000USD941,000USD1,069,000USD667,000USD558,000USD420,000USD5,716,000USD
    Short Long Term Debt5,304,000USD——275,000USD———5,716,000USD
    Short Long Term Debt Total76,865,000USD42,254,000USD41,557,000USD27,065,000USD3,180,000USD22,540,000USD107,532,000USD120,453,000USD
    Long Term Debt81,330,000USD40,724,000USD40,086,000USD24,526,000USD249,000USD19,051,000USD103,623,000USD114,737,000USD
    Short Term Investments8,813,000USD0USD59,220,000USD12,961,000USD79,004,000USD73,444,000USD31,992,000USD119,786,000USD
    Net Receivables8,813,000USD200,000USD42,000USD31,000USD516,000USD239,000USD2,524,000USD306,000USD
    Inventory1,833,000USD0USD——-100,772,000USD0USD3,096,000USD327,000USD
    Accounts Payable12,448,000USD4,026,000USD7,184,000USD4,901,000USD2,302,000USD1,875,000USD9,655,000USD10,253,000USD
    Property Plant Equipment Net491,000USD1,437,000USD1,208,000USD1,881,000USD2,512,000USD3,142,000USD4,024,000USD1,369,000USD
    Property Plant Equipment Gross2,113,000USD3,055,000USD2,800,000USD3,411,000USD4,187,000USD416,000USD4,024,000USD1,369,000USD
    Accumulated Other Comprehensive Income5,229,000USD—13,000USD—34,000USD53,000USD14,000USD127,000USD
    Common Stock Shares Outstanding69,309,000shares35,713,000shares22,054,000shares16,138,000shares14,533,833shares12,777,499shares6,214,833shares5,776,749shares
    Non Current Assets Total23,029,000USD6,577,000USD6,036,000USD2,180,000USD2,922,000USD9,411,000USD60,085,000USD23,977,000USD
    Non Current Liabilities Total116,977,000USD99,458,000USD65,964,000USD25,996,000USD2,513,000USD21,982,000USD107,982,000USD115,860,000USD
    Non Currrent Assets Other6,112,000USD5,140,000USD4,828,000USD58,000USD410,000USD274,000USD36,053,000USD1,031,000USD
    Net Working Capital151,145,000USD63,988,000USD117,302,000USD71,207,000USD87,150,000USD127,845,000USD55,071,000USD216,182,000USD
    Unclassified Current Assets-8,813,000USD———————
    Unclassified Current Liabilities-5,304,000USD—————-19,365,000USD-5,716,000USD
    Unclassified Non Current Liabilities35,647,000USD58,734,000USD25,878,000USD—————
    Unclassified Equity1,216,950,000USD926,626,000USD882,245,000USD784,874,000USD751,198,000USD707,698,000USD531,929,000USD499,734,000USD
    Current Deferred Revenue——327,000USD710,000USD——19,365,000USD—
    Other Assets———299,000USD410,000USD8,995,000USD36,053,000USD1,031,000USD
    Non Current Liabilities Other———1,470,000USD2,264,000USD2,931,000USD4,359,000USD1,123,000USD
    Net Tangible Assets———47,391,000USD87,559,000USD115,274,000USD-12,834,000USD102,722,000USD
    Long Term Investments————0USD5,995,000USD0USD—
    Unclassified Non Current Assets—————-8,995,000USD-36,053,000USD-1,031,000USD
    Other Liab——————870,000USD1,123,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-36,591,000USD-32,916,000USD-98,518,000USD-25,934,000USD-52,103,000USD-64,551,000USD-23,967,000USD-8,256,000USD
    Depreciation279,000USD298,000USD292,000USD128,000USD10,000USD7,000USD7,000USD6,000USD
    Stock Based Compensation2,046,000USD2,025,000USD2,178,000USD3,413,000USD1,788,000USD2,019,000USD1,935,000USD1,905,000USD
    Other Non Cash Items-9,283,000USD-9,614,000USD56,968,000USD-18,892,000USD7,364,000USD32,783,000USD-13,307,000USD-10,242,000USD
    Change To Account Receivables-1,345,000USD-2,097,000USD-4,640,000USD-2,076,000USD0USD0USD10,625,000USD-10,599,000USD
    Change To Inventory-454,000USD-39,000USD-626,000USD-1,168,000USD0USD———
    Change In Working Capital-8,567,000USD10,253,000USD2,864,000USD8,622,000USD4,265,000USD4,643,000USD11,537,000USD-10,983,000USD
    Total Cash From Operating Activities-52,116,000USD-29,954,000USD-36,216,000USD-32,663,000USD-38,676,000USD-25,099,000USD-23,795,000USD-27,570,000USD
    Capital Expenditures0USD-1,345,000USD0USD0USD0USD0USD0USD-7,000USD
    Free Cash Flow-52,116,000USD-31,299,000USD-36,216,000USD-32,663,000USD-38,676,000USD-25,099,000USD-23,795,000USD-27,577,000USD
    Investments-16,015,000USD0USD-8,279,000USD0USD0USD0USD0USD28,993,000USD
    Total Cashflows From Investing Activities-16,015,000USD-1,345,000USD-8,279,000USD-1,000USD30,000USD207,000USD-212,000USD28,993,000USD
    Net Borrowings0USD1,000USD0USD0USD32,420,000USD0USD-150,000USD—
    Total Cash From Financing Activities28,692,000USD98,583,000USD17,879,000USD79,416,000USD67,427,000USD742,000USD53,599,000USD-405,000USD
    Issuance Of Capital Stock0USD96,881,000USD0USD69,933,000USD30,162,000USD0USD14,221,000USD0USD
    Change In Cash-39,439,000USD67,284,000USD-26,616,000USD46,753,000USD28,751,000USD-24,357,000USD29,804,000USD1,018,000USD
    Begin Period Cash Flow205,231,000USD137,947,000USD164,322,000USD117,810,000USD89,059,000USD113,416,000USD83,612,000USD82,594,000USD
    End Period Cash Flow165,792,000USD205,231,000USD137,706,000USD164,563,000USD117,810,000USD89,059,000USD113,416,000USD83,612,000USD
    Other Cashflows From Investing Activities119,000USD-1,345,000USD-8,308,000USD—————
    Other Cashflows From Financing Activities-721,000USD-188,000USD-278,000USD9,483,000USD4,845,000USD-133,000USD39,528,000USD-156,000USD
    Unclassified Financing Cash Flow29,413,000USD1,889,000USD18,157,000USD—————
    Unclassified Investing Cash Flow—1,345,000USD8,308,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-209,471,000USD-130,637,000USD-87,367,000USD-73,812,000USD-71,200,000USD-67,726,000USD-149,209,000USD-72,434,000USD
    Depreciation728,000USD26,000USD62,000USD-36,000USD72,000USD1,255,000USD2,179,000USD1,419,000USD
    Stock Based Compensation9,404,000USD7,342,000USD5,860,000USD6,047,000USD7,711,000USD8,118,000USD8,539,000USD6,671,000USD
    Other Non Cash Items35,826,000USD14,780,000USD-4,058,000USD228,000USD9,331,000USD10,319,000USD7,131,000USD1,814,000USD
    Change To Account Receivables-8,813,000USD-200,000USD31,000USD485,000USD-277,000USD2,285,000USD-2,218,000USD-306,000USD
    Change To Inventory-1,833,000USD0USD0USD0USD0USD3,096,000USD-2,769,000USD-327,000USD
    Change In Working Capital26,004,000USD3,718,000USD-957,000USD3,900,000USD584,000USD11,635,000USD-7,799,000USD13,650,000USD
    Total Cash From Operating Activities-137,509,000USD-104,771,000USD-86,460,000USD-63,673,000USD-53,502,000USD-33,506,000USD-138,518,000USD-74,515,000USD
    Capital Expenditures-9,624,000USD-28,000USD-7,000USD0USD-196,000USD-33,000USD-7,000USD-23,507,000USD
    Free Cash Flow-137,509,000USD-104,799,000USD-86,460,000USD-63,673,000USD-53,698,000USD-33,539,000USD-138,525,000USD-98,022,000USD
    Investments0USD59,972,000USD-43,858,000USD66,185,000USD283,000USD-47,363,000USD89,620,000USD-114,952,000USD
    Total Cashflows From Investing Activities-9,624,000USD59,972,000USD-44,447,000USD66,185,000USD87,000USD-47,363,000USD89,613,000USD-138,377,000USD
    Net Borrowings32,421,000USD-150,000USD14,618,000USD24,148,000USD1,087,000USD-37,366,000USD-2,504,000USD155,197,000USD
    Total Cash From Financing Activities263,305,000USD54,782,000USD134,194,000USD51,784,000USD6,885,000USD69,630,000USD-2,441,000USD261,162,000USD
    Issuance Of Capital Stock196,976,000USD14,221,000USD119,519,000USD27,354,000USD6,723,000USD106,059,000USD—105,156,000USD
    Change In Cash116,172,000USD9,983,000USD3,287,000USD54,296,000USD-46,530,000USD-11,239,000USD-51,346,000USD48,270,000USD
    Begin Period Cash Flow89,059,000USD79,076,000USD75,789,000USD21,493,000USD68,023,000USD79,262,000USD130,608,000USD82,338,000USD
    End Period Cash Flow205,231,000USD89,059,000USD79,076,000USD75,789,000USD21,493,000USD68,023,000USD79,262,000USD130,608,000USD
    Other Cashflows From Investing Activities-29,000USD5,000USD-7,000USD66,185,000USD-9,331,000USD-10,319,000USD89,620,000USD-21,918,000USD
    Other Cashflows From Financing Activities263,305,000USD40,711,000USD28,156,000USD282,000USD162,000USD937,000USD9,801,000USD809,000USD
    Unclassified Financing Cash Flow-229,397,000USD—-28,099,000USD—6,561,000USD106,344,000USD-9,655,000USD—
    Change To Liabilities———1,961,000USD2,419,000USD-7,976,000USD-1,935,000USD15,450,000USD
    Dividends Paid———0USD0USD0USD-15,000USD—
    Sale Purchase Of Stock———27,636,000USD-925,000USD-285,000USD-68,000USD105,965,000USD
    Cash And Cash Equivalents Changes———54,296,000USD-46,530,000USD-11,239,000USD-51,346,000USD48,270,000USD
    Unclassified Investing Cash Flow———-66,185,000USD9,331,000USD10,352,000USD-89,620,000USD22,000,000USD
    Unclassified Operating Cash Flow—————2,893,000USD—-25,635,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2025Yearly · 2025-12-31ProductCopiktra License And Related Assets0USD0001104659-26-023444
    FY 2025Yearly · 2025-12-31ProductProduct30,914,000USD0001104659-26-023444
    Q3 2025Quarterly · 2025-09-30ProductCopiktra License And Related Assets0USD0001104659-25-106279
    Q3 2025Quarterly · 2025-09-30ProductProduct11,242,000USD0001104659-25-106279
    FY 2021Yearly · 2021-12-31ProductCopiktra License And Related Assets1,447,000USD0001558370-24-003250
    FY 2021Yearly · 2021-12-31ProductTransition Services Revenue606,000USD0001558370-24-003250
    Q4 2021Quarterly · 2021-12-31ProductCopiktra License And Related Assets545,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductTransition Services Revenue0USDLegacy provider
    Q3 2021Quarterly · 2021-09-30ProductCopiktra License And Related Assets0USD0001558370-22-016278
    Q3 2021Quarterly · 2021-09-30ProductTransition Services Revenue2,000USD0001558370-22-016278
    Q2 2021Quarterly · 2021-06-30ProductCopiktra License And Related Assets52,000USD0001558370-22-012638
    Q2 2021Quarterly · 2021-06-30ProductTransition Services Revenue448,000USD0001558370-22-012638
    Q1 2021Quarterly · 2021-03-31ProductCopiktra License And Related Assets850,000USD0001558370-22-007848
    Q1 2021Quarterly · 2021-03-31ProductTransition Services Revenue156,000USD0001558370-22-007848
    FY 2020Yearly · 2020-12-31ProductCopiktra License And Related Assets70,000,000USD0001558370-23-003738
    FY 2020Yearly · 2020-12-31ProductLicense2,912,000USD0001558370-23-003738
    FY 2020Yearly · 2020-12-31ProductProduct15,232,000USD0001558370-23-003738
    FY 2020Yearly · 2020-12-31ProductTransition Services Revenue372,000USD0001558370-23-003738
    Q4 2020Quarterly · 2020-12-31ProductProduct134,000USD0001558370-21-003211
    Q4 2020Quarterly · 2020-12-31ProductTransition Services Revenue372,000USD0001558370-21-003211
    Q3 2020Quarterly · 2020-09-30ProductCopiktra License And Related Assets70,000,000USD0001558370-21-014621
    Q3 2020Quarterly · 2020-09-30ProductLicense2,818,000USD0001558370-21-014621
    Q3 2020Quarterly · 2020-09-30ProductProduct5,829,000USD0001558370-21-014621
    Q2 2020Quarterly · 2020-06-30ProductLicense72,000USD0001558370-21-009812
    Q2 2020Quarterly · 2020-06-30ProductProduct4,235,000USD0001558370-21-009812
    FY 2019Yearly · 2019-12-31ProductLicense5,117,000USD0001558370-22-004498
    FY 2019Yearly · 2019-12-31ProductProduct12,339,000USD0001558370-22-004498
    FY 2018Yearly · 2018-12-31ProductLicense25,000,000USD0001558370-21-003211
    FY 2018Yearly · 2018-12-31ProductProduct1,718,000USD0001558370-21-003211

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.